On February 5, 2024, the company announced an increase in its equity buyback plan. The company increased its authorization by an additional amount of CNY 300 million, thereby increasing the total plan term monetary value authorization to CNY 600 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 CNY | +0.64% | -3.66% | -8.41% |
1st Jan change | Capi. | |
---|---|---|
-8.41% | 628M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Yabao Pharmaceutical Group Co., Ltd announces an Increase in Equity Buyback.